DHX36 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.509000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.944600E-01
Normal-vs-Stage2
6.499600E-01
Normal-vs-Stage3
1.233210E-01
Normal-vs-Stage4
5.406200E-01
Stage1-vs-Stage2
8.796800E-01
Stage1-vs-Stage3
3.017000E-01
Stage1-vs-Stage4
2.170200E-01
Stage2-vs-Stage3
2.625200E-01
Stage2-vs-Stage4
1.177990E-01
Stage3-vs-Stage4
7.579700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.141000E-01
Normal-vs-AfricanAmerican
7.938400E-01
Normal-vs-Asian
1.878980E-01
Caucasian-vs-AfricanAmerican
2.124000E-01
Caucasian-vs-Asian
1.808970E-01
AfricanAmerican-vs-Asian
8.336100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.555200E-01
Normal-vs-Female
7.970200E-01
Male-vs-Female
1.837180E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.684200E-01
Normal-vs-Age(41-60Yrs)
9.864800E-01
Normal-vs-Age(61-80Yrs)
5.393800E-01
Normal-vs-Age(81-100Yrs)
2.780800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.264800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.388800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.985600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.904400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.962200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.092600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.519590E-01
Normal-vs-Daily Drinker
6.518300E-02
Normal-vs-Weekly Drinker
3.872000E-01
Normal-vs-Occasional Drinker
7.857400E-01
Normal-vs-Social Drinker
9.911200E-01
Non Drinker-vs-Daily Drinker
4.553800E-01
Non Drinker-vs-Weekly Drinker
5.389400E-01
Non Drinker-vs-Occasional Drinker
1.777760E-02
Non Drinker-vs-Social Drinker
8.462400E-02
Daily Drinker-vs-Weekly Drinker
2.430200E-01
Daily Drinker-vs-Occasional Drinker
6.883800E-03
Daily Drinker-vs-Social Drinker
3.779500E-02
Weekly Drinker-vs-Occasional Drinker
9.357700E-02
Weekly Drinker-vs-Social Drinker
2.430400E-01
Occasional Drinker-vs-Social Drinker
6.165600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.321800E-01
Normal-vs-Grade 2
3.384100E-02
Normal-vs-Grade 3
4.043600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.688400E-01
Grade 1-vs-Grade 3
2.716800E-01
Grade 1-vs-Grade 4
1.321800E-01
Grade 2-vs-Grade 3
4.634400E-01
Grade 2-vs-Grade 4
3.384100E-02
Grade 3-vs-Grade 4
4.043600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.874200E-01
Normal-vs-NonDiabetic
5.717400E-01
Diabetic-vs-NonDiabetic
2.557200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.732400E-02
Normal-vs-NoPancreatitis
5.790800E-01
Pancreatitis-vs-NoPancreatitis
4.687600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.316600E-01
Normal-vs-N1
6.875800E-01
N0-vs-N1
6.445800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.797600E-01
Normal-vs-TP53-NonMutant
7.703800E-01
TP53-Mutant-vs-TP53-NonMutant
3.788000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
